Thus, loss of Sar1B's lipoprotein secretion-promoting activity appears to impair apoB lipoprotein production, albeit to a lesser extent than the impairment that occurs in abetalipoproteinemia. This evidence concerns the gene APOB and abetalipoproteinemia.